Knobil Katharine has filed 7 insider transactions across 3 companies since June 2024.
Most recent transaction: a grant/award of 137330 shares of Marker Therapeutics, Inc. ($MRKR) on November 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | Marker Therapeutics, Inc. | $MRKR | Knobil Katharine | Director | A | Stock Option (Right to Buy) | 137330 | $0.00 | 137,330.0000 | 16,757,678 | 9999.99% | 0.82% |
| Nov. 17, 2025 | Marker Therapeutics, Inc. | $MRKR | Knobil Katharine | Director | A | Stock Option (Right to Buy) | 84411 | $0.00 | 84,411.0000 | 16,757,678 | 9999.99% | 0.50% |
| June 11, 2025 | Korro Bio, Inc. | $KRRO | Knobil Katharine | Not found | A | Stock Option (Right to Buy) | 6010 | $0.00 | 6,010.0000 | 9,388,902 | 9999.99% | 0.06% |
| June 5, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Knobil Katharine | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| Feb. 12, 2025 | Marker Therapeutics, Inc. | $MRKR | Knobil Katharine | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,980,207 | 9999.99% | 0.33% |
| Aug. 26, 2024 | Korro Bio, Inc. | $KRRO | Knobil Katharine | Not found | A | Stock Option (Right to Buy) | 9041 | $0.00 | 9,041.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Knobil Katharine | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |